Today: 27 April 2026

AllianceBernstein stock jumps 7.5%; AB traders eye Fed week and Feb. 5 earnings

AllianceBernstein stock jumps 7.5%; AB traders eye Fed week and Feb. 5 earnings

AllianceBernstein units traded near $41.88 premarket Tuesday after jumping 7.49% Monday, with 1.63 million units changing hands. The firm’s assets under management rose to $867 billion in December, though net flows were slightly negative. No company statement has explained Monday’s surge. AllianceBernstein reports Q4 results before the market opens Feb. 5.
27 January 2026
···
Cloudflare stock jumps again in premarket as “Clawdbot” buzz puts NET back in play

Cloudflare stock jumps again in premarket as “Clawdbot” buzz puts NET back in play

Cloudflare shares rose 6.8% to $202.20 in Tuesday premarket trading after a 9.2% jump Monday, driven by buzz around the open-source AI agent Clawdbot. Wolfe Research linked the surge to social media interest and noted Cloudflare’s edge network could benefit from increased AI agent use. Investors await Cloudflare’s earnings on February 10 and the Federal Reserve’s policy decision this week.
27 January 2026
··
Humana stock tumbles in premarket after CMS flags near-flat 2027 Medicare Advantage rates

Humana stock tumbles in premarket after CMS flags near-flat 2027 Medicare Advantage rates

Humana shares fell about 12% in premarket trading Tuesday after a U.S. proposal signaled minimal Medicare Advantage payment growth for 2027. The Centers for Medicare & Medicaid Services set a net average increase of 0.09%, citing risk score changes and new limits on chart review diagnoses. UnitedHealth and CVS Health also dropped around 9%. Investors await the April 6 final rate notice.
27 January 2026
·
CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS stock slides before the bell as Medicare Advantage rate shock hits insurers

CVS Health shares fell about 9% in premarket trading after CMS announced a 0.09% net average payment increase for 2027 Medicare Advantage plans, far below investor expectations. The agency set a Feb. 25 deadline for comments and will finalize rates by April 6. UnitedHealth and Humana also dropped in after-hours trading. Insurers face pressure as Medicare Advantage remains a key profit source.
27 January 2026
·
Micron stock jumps in premarket on $24B Singapore fab plan as AI memory crunch tightens

Micron stock jumps in premarket on $24B Singapore fab plan as AI memory crunch tightens

Micron shares rose about 4% in premarket trading Tuesday after the company announced a $24 billion expansion of its Singapore manufacturing site, with wafer production set for late 2028. The move comes as memory chip supply remains tight and analysts expect enterprise SSD prices to jump up to 60%. Executive vice president Manish Bhatia sold over 26,000 shares last week, regulatory filings show.
27 January 2026
··
CoreWeave stock price: Nvidia’s $2 billion buy puts CRWV back in play before the open

CoreWeave stock price: Nvidia’s $2 billion buy puts CRWV back in play before the open

CoreWeave shares rose 5.7% to $98.31 premarket Monday after Nvidia announced a $2 billion investment at $87.20 per share, becoming the company’s second-largest shareholder. The private sale adds nearly 23 million shares to Nvidia’s stake. CoreWeave said it will use the funds to expand data centers and research, not to buy Nvidia processors. Investors are watching if CRWV holds above Nvidia’s purchase price ahead of a busy tech earnings week.
27 January 2026
···
UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth stock slides premarket as Medicare Advantage rate plan shakes insurers before earnings

UnitedHealth shares fell 8.3% to $322.32 in premarket trading after CMS proposed a near-flat 0.09% average payment increase for 2027 Medicare Advantage plans and stricter rules on diagnosis data. The move triggered a broad selloff in managed-care stocks, with CVS Health and Humana also dropping sharply. UnitedHealth is set to report earnings and its 2026 outlook before the market opens. CMS will accept comments on the proposal until Feb. 25.
27 January 2026
··
SSE PLC share price ticks up in London as Jan 30 dividend nears — what to watch next

SSE PLC share price ticks up in London as Jan 30 dividend nears — what to watch next

SSE shares edged up 0.1% to 2,358 pence in early London trading Tuesday, after a 1.5% gain Monday. Volume remained thin, with about 308,000 shares traded versus a three-month average of 3.6 million. Investors await an interim dividend payment and scrip share admission on Jan. 30, followed by a Q3 trading update on Feb. 4. UK 10-year gilt yields rose to 4.509%, keeping utilities in focus.
27 January 2026
···
Babcock share price today: BAB.L slips despite fresh buybacks and higher broker targets

Babcock share price today: BAB.L slips despite fresh buybacks and higher broker targets

Babcock shares slipped 0.34% to 1,449p in early London trading after announcing further share buybacks. Jefferies and JPMorgan raised their target prices to 1,670p and 1,700p, respectively, as investors watch for a June board handover. The company reaffirmed its FY26 outlook and margin target, citing contracted revenue and new Arrowhead licence deals in Indonesia.
27 January 2026
··
1 … 431 432 433 434 435 … 1,871

Stock Market Today

  • Structure Therapeutics (GPCR) Valuation Falters Amid Share Price Decline
    April 26, 2026, 10:46 PM EDT. Structure Therapeutics (GPCR) shares dropped to $45.49, marking a 49.21% decline over 90 days despite a strong 91.62% one-year total return. The biotech's price-to-book (P/B) ratio of 2.1x appears undervalued versus peers' average of 31.2x and the US pharmaceuticals sector average of 2.6x, suggesting cautious investor sentiment. This ratio compares market value to book value, often used for early-stage or loss-making companies. GPCR faces risks from ongoing clinical trials for GSBR-1290 and significant net losses of $141.2 million. Analyst forecasts predict 56.5% annual revenue growth, but uncertainties linger. Investors should balance potential gains with risks, monitoring clinical outcomes and funding capabilities amid a volatile healthcare sector.

Latest article

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

26 April 2026
SoFi will report first-quarter results before markets open April 29, with management projecting about $1.04 billion in adjusted net revenue and adjusted EPS of 12 cents. Shares closed at $18.44 Friday, valuing the company at $23.8 billion. The company recently launched a digital HELOC and formed a Real Estate Advisory Council. Last quarter, loan originations rose 46% to $10.5 billion and fee-based revenue climbed 53%.
Go toTop